- Did you mean
- commercialisation
Search results - 7 results
Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre.
diagnostic assays for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and later to assess the quality of commercial kits. To meet the growing demand for decentralised testing, both clinical ...
Towards clinical breakpoints for non-tuberculous mycobacteria- Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
Mycobacterium abscessus (MAB) obtained by commercial broth microdilution (SLOMYCOI and RAPMYCOI) from 12 laboratories. Epidemiological cut-off values (ECOFF s) and tentative ECOFF s (TECOFF s) were determined by ...
Healthy Data, an online citizen consultation about health data reuse – intermediate report
wrote about ‘my data’, ‘I own my data’, ‘I should be in control’. On the other hand, they would talk about reuse systems, platforms, scientific research, databases, commercial use, … which can all be ...
Le Débat des Données, une consultation citoyenne en ligne sur la réutilisation des données de santé – Rapport intermédiaire
»). D’autre part, ils ont discuté de systèmes de réutilisation des données, de plateformes, de recherche scientifique, de base de données, d’usage commercial, etc. qui peuvent être définis comme des ...
Review on current scientific literature and overview of commercially available methods for on-site DNA isolation
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Manal AbuOun; Indre Navickaite; Sigrid C.J. De Keersmaecker; Mathieu Gand; Søren Persson; Valeria Michelacci; Francesca Marotta; Marco Di Domenico; Giuliano Garofolo ...
Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay.
(e.g. virus neutralization assays), or are expensive with suboptimal specificity (e.g. commercial ELISA s and RDT s). Bead-based assays offer a cost-effective alternative and allow for multiplexing to ...
New QSAR models to predict chromosome damaging potential based on the in vivo micronucleus test
overall better performance than existing free and commercial models for the same endpoint, while demonstrating high coverage. Health Topics: Health and disease monitoring Surveillance de la santé et des ...